Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 167

    Boehringer Ingelheim, GNA Biosolutions partners on emergency diagnostics development

    Boehringer Ingelheim, GNA Biosolutions partners on emergency diagnostics development

    Farhat Nasim28 Feb 2019 9:00 AM IST
    The Boehringer and GNA Biosolutions collaboration further emphasises the role of GNA Biosolutions in the rapidly developing field of extra-laboratory...
    True North to acquire controlling stake in Max Bupa Health Insurance for Rs 511 crore

    True North to acquire controlling stake in Max Bupa Health Insurance for Rs 511 crore

    Garima27 Feb 2019 12:51 PM IST
    The transaction will lead to a cash inflow of Rs 511 crore for Max India. The company intends to utilize the proceeds to invest in both existing and...
    Lupin launches Minocycline Hydrochloride extended release tablets in US

    Lupin launches Minocycline Hydrochloride extended release tablets in US

    Farhat Nasim27 Feb 2019 9:40 AM IST
    The company has launched Minocycline Hydrochloride extended-release tablets USP in the strength of 55 mg, after receiving approval from the United...
    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Farhat Nasim27 Feb 2019 9:30 AM IST
    The company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
    Novartis to pump up cardio business with Ionis deal worth Rs 15 crore

    Novartis to pump up cardio business with Ionis deal worth Rs 15 crore

    Garima27 Feb 2019 9:15 AM IST
    ZURICH: Novartis will pay $150 million to Ionis Pharmaceuticals to license an RNA-targeting cardiovascular drug as the Swiss company aims to bolster...
    General Electric sells biopharma business to Danaher for Rs 2.14 crore

    General Electric sells biopharma business to Danaher for Rs 2.14 crore

    Garima27 Feb 2019 9:00 AM IST
    The biopharma business, part of its life sciences unit, generated revenue of about $3 billion in 2018. It makes instruments and software that support...
    Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

    Lupin gets USFDA nod to Methylprednisolone tablets to treat inflammation

    Farhat Nasim26 Feb 2019 9:50 AM IST
    The company has received approval from the US Food and Drug Administration (USFDA) to market Methylprednisolone tablets, a generic version of...
    Shilpa Medicare gets tentative USFDA nod for Dimethyl Fumarate delayed release capsules

    Shilpa Medicare gets tentative USFDA nod for Dimethyl Fumarate delayed release capsules

    Farhat Nasim26 Feb 2019 9:40 AM IST
    Quoting IQVIA MAT second quarter 2018 data, Shilpa Medicare said the US market for Dimethyl Fumarate delayed-release capsules is approximately USD...
    Roche to buy Spark Therapeutics in Rs 430 crore deal

    Roche to buy Spark Therapeutics in Rs 430 crore deal

    Garima26 Feb 2019 9:30 AM IST
    Roche will acquire U.S.-based Spark for $114.50 per share, a premium of about 122 per cent to Spark's closing price on Feb. 22, the Swiss company said...
    Sanofi, Regeneron loses patent challenge to Amgen cholesterol drug Repatha

    Sanofi, Regeneron loses patent challenge to Amgen cholesterol drug Repatha

    Garima26 Feb 2019 9:05 AM IST
    Sanofi and Regeneron had stipulated that if the two Amgen patents were valid, their jointly developed cholesterol drug Praluent infringed them.U.S:...
    Diabetics, insuline providers stockpile over Brexit fears

    Diabetics, insuline providers stockpile over Brexit fears

    Farhat Nasim26 Feb 2019 8:59 AM IST
    A no-deal Brexit would almost certainly mean re-establishing customs and health controls, which could lead to delays at the border.London: Diabetics...
    Pharmaceutical residues in fresh water pose environmental risk

    Pharmaceutical residues in fresh water pose environmental risk

    Farhat Nasim25 Feb 2019 1:07 PM IST
    Washington: A new research now finds that over the past two decades, concentrations of pharmaceuticals have increased in freshwater sources all over...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok